Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share, spending HK$9.38 million in aggregate. The volume-weighted average price was approximately HK$2.27 per share. All of the shares will be cancelled.

Following the latest transaction, shares bought back under the mandate granted on 26 June 2025 total 94.48 million, representing 3.44 % of the company’s issued share capital at the time the mandate was approved.

As at the disclosure date, 54.82 million repurchased shares are pending cancellation, equal to roughly 2.03 % of JXR’s current issued share base of 2.71 billion shares. The reported transactions leave the company with sufficient headroom to repurchase a further 179.99 million shares before reaching the 10 % limit authorised by shareholders.

A 30-day moratorium applies to any new share issuance or sale of treasury shares up to 5 July 2026, in accordance with Hong Kong Listing Rules.